Is double documentation of high-risk medications best practice for patient safety?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The evidence suggests that double documentation of high-risk medications enhances safety by reducing errors, but implementation may vary depending on clinical context and resources.

Fields of Study & Subjects

Patient Safety and Medication Errors Electronic Health Records Systems Pharmaceutical Practices and Patient Outcomes

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
4 February 2026
Language
EN